CN104840703A - Medicine preparation for treating breast cancer - Google Patents

Medicine preparation for treating breast cancer Download PDF

Info

Publication number
CN104840703A
CN104840703A CN201510310011.4A CN201510310011A CN104840703A CN 104840703 A CN104840703 A CN 104840703A CN 201510310011 A CN201510310011 A CN 201510310011A CN 104840703 A CN104840703 A CN 104840703A
Authority
CN
China
Prior art keywords
parts
radix
treatment
breast cancer
medicine preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510310011.4A
Other languages
Chinese (zh)
Inventor
徐艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510310011.4A priority Critical patent/CN104840703A/en
Publication of CN104840703A publication Critical patent/CN104840703A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the field of medicines, and provides a medicine preparation for treating breast cancer. The medicine preparation is prepared from the following raw materials: 20 parts of small diuranthera root, 15 parts of Hongkong kumquat leaves, 18 parts of martin fig root and stem, 20 parts of devil rush rhizome, 16 parts of kaleniczenk euphorbia herb, 20 parts of pampanin shuteria herb, 18 parts of common yellow oxalis herb, 15 parts of puberulous glochidion root, 16 parts of common floweringquince seeds, 18 parts of Chinese holly roots, 20 parts of fernleaf dichocarpum roots, 15 parts of androsace umbellate, 16 parts of Chinese photinia fruit, 18 parts of common alocasia fruit and 20 parts of apricot-leaved adenophora leaves. The medicine preparation provided by the invention is capable of treating breast cancer.

Description

A kind of pharmaceutical preparation being used for the treatment of breast carcinoma
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to a kind of pharmaceutical preparation being used for the treatment of breast carcinoma and its preparation method and application.
Background technology
Current breast carcinoma has become the able-bodied kinds of tumor of threat women.Whole world breast cancer incidence starts always in rising trend from late 1970s.The U.S. 8 women just have 1 people in life and suffer from breast cancer.China is not the country occurred frequently of breast carcinoma, but unsuitable optimistic, and the growth rate of China's breast cancer incidence but exceeds national 1 ~ 2 percentage point occurred frequently in recent years.Because sickness rate is high, for this reason, be bursting to and develop the needs that more medicines for the treatment of breast carcinoma safely and effectively meet clinical treatment.
Summary of the invention
In order to solve the problem, the object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of breast cancer disease.In order to reach this object, adopt following technical scheme:
Technical scheme: a kind of pharmaceutical preparation being used for the treatment of breast carcinoma, the active component contained by it is extracted by following weight crude drug and is prepared from: Radix Diurantherae Minoris 20 parts, Folium Fortunellae Hindsii 15 parts, Radix seu Caulis fici Martinii 18 parts, Rhizoma Juci setchuensis 20 parts, Euphorbia kaleniczenkii Czerniaev 16 parts, Shuteria pampaniniana Hand.-Mazz. 20 parts, Herba Oxalidis Strictae 18 parts, Radix glochidionis puberi 15 parts, Semen Chaenomelis 16 parts, Radix Ilicis Cornutae 18 parts, Radix Dichocarpi Dalzielii 20 parts, Herba Androsaces Umbellatae (Herba Androsaces Coccineae) 15 parts, Chinese photinia fruit 16 parts, Fructus Alocasiae macrorrhizae 18 parts of, Folium Adenophorae Trachelioidis 20 parts.
The described pharmaceutical preparation being used for the treatment of breast carcinoma, dosage form is pharmaceutically acceptable granule, tablet, capsule.
The described pharmaceutical preparation being used for the treatment of breast carcinoma, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make granule, tablet, capsule.
The described application of pharmaceutical preparation in preparation treatment breast cancer medicines being used for the treatment of breast carcinoma.
Radix Diurantherae Minoris is the root of the little Radix diurantherae majoris of liliaceous plant.Folium Fortunellae Hindsii is the leaf of rutaceae mountain Fructus Citri tangerinae.Radix seu Caulis fici Martinii is root, the stem of moraceae plants Martin fig.Rhizoma Juci setchuensis is the rhizome that rush family plant intends Medulla Junci.Euphorbia kaleniczenkii Czerniaev is the herb of euphorbia plant Euphorbia kaleniczenkii Czerniaev.Shuteria pampaniniana Hand.-Mazz. is the herb of leguminous plant hair place bud bean.Herba Oxalidis Strictae is the tight oxalic herb of Oxalidaceae plant.Radix glochidionis puberi is the root of euphorbia plant Fructus glochidionis puberi(Herba Glochidii Puberi).Semen Chaenomelis is the seed of rosaceous plant chaenomeles lagenaria.Radix Ilicis Cornutae is the root of holly plant Ilex cornuta Lindl..Radix Dichocarpi Dalzielii is the root of ranunculaceae plant fern leaf herringbone fruit.Herba Androsaces Umbellatae (Herba Androsaces Coccineae) is the herb of Ofthe Primulaceae Caulis et folium clerodendri bungei Herba Androsaces Umbellatae (Herba Androsaces Coccineae).Chinese photinia fruit is the fruit of rosaceous plant Chinese photinia.Fructus Alocasiae macrorrhizae is the fruit of aroid Rhizoma alcasiae odorae.Folium Adenophorae Trachelioidis is the Seedling leaf of Campanulaceae Radix Adenophorae Trachelioidis.
Beneficial effect: Radix Diurantherae Minoris of the present invention, Folium Fortunellae Hindsii, Radix seu Caulis fici Martinii, Rhizoma Juci setchuensis heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling is monarch drug, Euphorbia kaleniczenkii Czerniaev, Shuteria pampaniniana Hand.-Mazz., Herba Oxalidis Strictae, Radix glochidionis puberi supplementing QI for promoting the production of body fluid are ministerial drug, Semen Chaenomelis, Radix Ilicis Cornutae, Radix Dichocarpi Dalzielii, Herba Androsaces Umbellatae (Herba Androsaces Coccineae), Chinese photinia fruit, Fructus Alocasiae macrorrhizae, Folium Adenophorae Trachelioidis are adjuvant, full side's treatment breast carcinoma successful.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, the preparation of granule embodiment: get Radix Diurantherae Minoris 20g, Folium Fortunellae Hindsii 15g, Radix seu Caulis fici Martinii 18g, Rhizoma Juci setchuensis 20g, Euphorbia kaleniczenkii Czerniaev 16g, Shuteria pampaniniana Hand.-Mazz. 20g, Herba Oxalidis Strictae 18g, Radix glochidionis puberi 15g, Semen Chaenomelis 16g, Radix Ilicis Cornutae 18g, Radix Dichocarpi Dalzielii 20g, Herba Androsaces Umbellatae (Herba Androsaces Coccineae) 15g, Chinese photinia fruit 16g, Fructus Alocasiae macrorrhizae 18g, Folium Adenophorae Trachelioidis 20g, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add starch 50g, granulate, make granule.
2, the preparation of Tablets Example: get Radix Diurantherae Minoris 20g, Folium Fortunellae Hindsii 15g, Radix seu Caulis fici Martinii 18g, Rhizoma Juci setchuensis 20g, Euphorbia kaleniczenkii Czerniaev 16g, Shuteria pampaniniana Hand.-Mazz. 20g, Herba Oxalidis Strictae 18g, Radix glochidionis puberi 15g, Semen Chaenomelis 16g, Radix Ilicis Cornutae 18g, Radix Dichocarpi Dalzielii 20g, Herba Androsaces Umbellatae (Herba Androsaces Coccineae) 15g, Chinese photinia fruit 16g, Fructus Alocasiae macrorrhizae 18g, Folium Adenophorae Trachelioidis 20g, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add dextrin 50g, granulate, tabletting, make tablet.
3, the preparation of capsule embodiment: get Radix Diurantherae Minoris 20g, Folium Fortunellae Hindsii 15g, Radix seu Caulis fici Martinii 18g, Rhizoma Juci setchuensis 20g, Euphorbia kaleniczenkii Czerniaev 16g, Shuteria pampaniniana Hand.-Mazz. 20g, Herba Oxalidis Strictae 18g, Radix glochidionis puberi 15g, Semen Chaenomelis 16g, Radix Ilicis Cornutae 18g, Radix Dichocarpi Dalzielii 20g, Herba Androsaces Umbellatae (Herba Androsaces Coccineae) 15g, Chinese photinia fruit 16g, Fructus Alocasiae macrorrhizae 18g, Folium Adenophorae Trachelioidis 20g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds starch 50g, granulates, fill, makes capsule.
4, pharmaceutical preparation treatment breast carcinoma of the present invention clinical research
Case selection: as the medicine for the treatment of breast carcinoma, select the routine clinical observation of patient with breast cancer 80 of making a definite diagnosis, patient is divided into treatment group and matched group two groups at random, treatment group women 40 example, 35 ~ 61 years old age, 47.8 years old mean age, the course of disease 1 ~ 2 year; Matched group women 40 example, 34 ~ 64 years old age, 49.5 years old mean age, the course of disease 1 ~ 2 year; The course of disease, the degrees of symptoms for the treatment of group and matched group two groups of cases are basically identical, without significant difference, have comparability.
Medicament selection: the preparation method that treatment group takes above-mentioned granule embodiment prepares medicine of the present invention, oral, every day 3 times, each 1 time sooner or later, each 10g, after meal warm water delivery service; Within 12 days, be 1 course for the treatment of, 2 ~ 4 courses for the treatment of can fully recover, and the person of being in a bad way follows the doctor's advice the meal with wine amount of adding.
Matched group takes medroxyprogesterone acetate tablets, oral, a 100mg (50), 3 times on the one, or oral 500mg (250), and every day 1 ~ 2 time, as the maintenance dose after intramuscular injection.
Efficacy determination: (1) cures: lump disappears, and physical recovery is normal.(2) effective: lump obviously reduces, health takes a turn for the better to some extent.(3) effective: lump reduces to some extent, and health is clearly better.(4) invalid: by treating rear lump without reducing or expanding.Therapeutic effect: in table 1.
Table 1 liang group comparitive study
Group n Cure Effective Effectively Invalid Total effective rate (%)
Treatment group 40 14 18 5 3 92.5
Blank group 40 7 8 12 13 67.5
Visible the present invention has good therapeutic effect to breast carcinoma, and toxic and side effects does not occur treatments period.

Claims (2)

1. one kind is used for the treatment of the pharmaceutical preparation of breast carcinoma, it is characterized in that, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Radix Diurantherae Minoris 20 parts, Folium Fortunellae Hindsii 15 parts, Radix seu Caulis fici Martinii 18 parts, Rhizoma Juci setchuensis 20 parts, Euphorbia kaleniczenkii Czerniaev 16 parts, Shuteria pampaniniana Hand.-Mazz. 20 parts, Herba Oxalidis Strictae 18 parts, Radix glochidionis puberi 15 parts, Semen Chaenomelis 16 parts, Radix Ilicis Cornutae 18 parts, Radix Dichocarpi Dalzielii 20 parts, Herba Androsaces Umbellatae (Herba Androsaces Coccineae) 15 parts, Chinese photinia fruit 16 parts, Fructus Alocasiae macrorrhizae 18 parts of, Folium Adenophorae Trachelioidis 20 parts.
2. be used for the treatment of the application of pharmaceutical preparation in treatment breast cancer medicines of breast carcinoma according to claim 1.
CN201510310011.4A 2015-06-08 2015-06-08 Medicine preparation for treating breast cancer Pending CN104840703A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510310011.4A CN104840703A (en) 2015-06-08 2015-06-08 Medicine preparation for treating breast cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510310011.4A CN104840703A (en) 2015-06-08 2015-06-08 Medicine preparation for treating breast cancer

Publications (1)

Publication Number Publication Date
CN104840703A true CN104840703A (en) 2015-08-19

Family

ID=53840948

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510310011.4A Pending CN104840703A (en) 2015-06-08 2015-06-08 Medicine preparation for treating breast cancer

Country Status (1)

Country Link
CN (1) CN104840703A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105250523A (en) * 2015-09-12 2016-01-20 叶晖 Traditional Chinese medicine composition used for treating acute mastitis
CN105641271A (en) * 2016-01-26 2016-06-08 浙江医学高等专科学校 Colocasia antiquorum extract and traditional Chinese medicine composition including same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101700356A (en) * 2009-11-16 2010-05-05 贺芹芹 Traditional Chinese medicine composition for treating breast cancer
KR20140111185A (en) * 2013-03-08 2014-09-18 대한민국(농촌진흥청장) Composition comprising extract of polygonatum for inhibiting cell aging

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101700356A (en) * 2009-11-16 2010-05-05 贺芹芹 Traditional Chinese medicine composition for treating breast cancer
KR20140111185A (en) * 2013-03-08 2014-09-18 대한민국(농촌진흥청장) Composition comprising extract of polygonatum for inhibiting cell aging

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
孙志慧: "《食物养生一本全》", 31 May 2013, 天津科学技术出版社 *
张诗军等: "《肿瘤中医生物养生治疗学》", 31 July 2013, 广东科技出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105250523A (en) * 2015-09-12 2016-01-20 叶晖 Traditional Chinese medicine composition used for treating acute mastitis
CN105641271A (en) * 2016-01-26 2016-06-08 浙江医学高等专科学校 Colocasia antiquorum extract and traditional Chinese medicine composition including same

Similar Documents

Publication Publication Date Title
CN104491315A (en) Traditional Chinese medicine composition for treating irregular menstrual period
CN104922388A (en) Medicinal preparation for treating female climacteric syndromes
CN104840687A (en) Pharmaceutical preparation for treating pelvic inflammation
CN104840703A (en) Medicine preparation for treating breast cancer
CN105106627A (en) Medicinal preparation for treating diabetes
CN104906366A (en) Pharmaceutical preparation for treating delayed menorrhea
CN102988921B (en) Chinese medicinal composition for treating diarrhea as well as preparation method and application thereof
CN102429961A (en) Medicinal composition capsules for treating cold and preparation method thereof
CN104857393A (en) Pharmaceutical preparation for treating arrhythmia
CN104771744A (en) Traditional Chinese medicine composition for treating urticaria
CN105055924A (en) Medicine preparation used for treating migraine
CN105079394A (en) Pharmaceutic preparation for treating arrhythmia
CN104800497A (en) Traditional Chinese medicine composition for treating irregular menstruation of gynecology
CN104873943A (en) Pharmaceutic preparation for treating anxiety
CN105125996A (en) Pharmaceutical preparation for treating unstable angina pectoris of aged coronary heart disease
CN105288285A (en) Medicinal preparation for treating chronic bronchitis
CN105031481A (en) Pharmaceutic preparation for treating neurasthenia
CN105079717A (en) Pharmaceutical preparation for treating depression
CN105148074A (en) Medicinal preparation used for treating diabetes
CN105056118A (en) Medicinal preparation for treating breast cancer
CN104873654A (en) Pharmaceutic preparation for treating urticaria
CN104906310A (en) Medicine granules for treating neurasthenia
CN105106663A (en) Pharmaceutical preparation for treating arrhythmia
CN105288505A (en) Medicinal preparation for treating hyperlipidemia
CN105079674A (en) Medicinal preparation for treating chest stuffiness and pains

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150819